Opsens Inc
TSX:OPS

Watchlist Manager
Opsens Inc Logo
Opsens Inc
TSX:OPS
Watchlist
Price: 2.9 CAD Market Closed
Market Cap: 329.3m CAD
Have any thoughts about
Opsens Inc?
Write Note

Opsens Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Opsens Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Opsens Inc
TSX:OPS
Research & Development
-CA$11.3m
CAGR 3-Years
-28%
CAGR 5-Years
-25%
CAGR 10-Years
-20%
Titan Medical Inc
TSX:TMD
Research & Development
$14k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Profound Medical Corp
TSX:PRN
Research & Development
-$15.5m
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanalysis Scientific Corp
XTSX:NSCI
Research & Development
-CA$679k
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theralase Technologies Inc
XTSX:TLT
Research & Development
-CA$2.6m
CAGR 3-Years
-17%
CAGR 5-Years
-3%
CAGR 10-Years
-15%
MedMira Inc
XTSX:MIR
Research & Development
-CA$449.6k
CAGR 3-Years
-45%
CAGR 5-Years
-11%
CAGR 10-Years
-3%
No Stocks Found

Opsens Inc
Glance View

Market Cap
334.8m CAD
Industry
Health Care

Opsens, Inc. engages in the development, manufacture, supply, and installation of fiber optic systems for measuring pressure and temperature. The firm operates through two segments: Medical and Industrial. The Medical segment focuses on physiological measurement, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that is integrated in other medical devices. The company also includes optical sensor technology. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for industrial applications. The firm also offers an optical-based pressure guidewire (OptoWire) that is focused on improving the clinical outcome of patients with coronary artery disease.

OPS Intrinsic Value
2.72 CAD
Overvaluation 6%
Intrinsic Value
Price

See Also

What is Opsens Inc's Research & Development?
Research & Development
-11.3m CAD

Based on the financial report for Aug 31, 2023, Opsens Inc's Research & Development amounts to -11.3m CAD.

What is Opsens Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-20%

Over the last year, the Research & Development growth was -35%. The average annual Research & Development growth rates for Opsens Inc have been -28% over the past three years , -25% over the past five years , and -20% over the past ten years .

Back to Top